{"disease":{"id":"solid-organ-malignancies","name":"solid organ malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05148806","title":"Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies","phase":"","overall_status":"COMPLETED","enrollment_count":28411,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT01218555","title":"Study of Everolimus (RAD001) in Combination With Lenalidomide","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Emory University","has_results":true},{"nct_id":"NCT05719428","title":"Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"National University Hospital, Singapore","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}